Operating Lease, Right-of-Use Asset in USD of Vor Biopharma Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vor Biopharma Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2020 to Q3 2025.
  • Vor Biopharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $3.04M, a 91.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vor Biopharma Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $3.04M -$33.3M -91.6% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $24K* -$37.5M Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $33.7M -$5.12M -13.2% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $35M -$5.04M -12.6% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 $36.3M -$4.97M -12% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $37.6M -$4.89M -11.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $38.8M -$4.76M -10.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $40M -$4.4M -9.89% Dec 31, 2023 10-K 2025-03-20
Q3 2023 $41.3M -$4.13M -9.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $42.5M -$3.69M -7.99% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $43.6M +$22M +102% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $44.4M +$28.8M +184% Dec 31, 2022 10-K 2024-03-20
Q3 2022 $45.4M +$29.4M +183% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $46.1M +$29.8M +182% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $21.6M +$4.8M +28.6% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $15.7M -$1.45M -8.45% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $16M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $16.4M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $16.8M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $17.1M Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.